MMP9 and central nervous system cancer: Immunohistochemical analyses of pioglitazone-treatedanimals revealed that protein levels of MMP-9 (matrix metalloproteinase 9), which has shown to be intimatelyinvolved in glioma migration and invasion [7], were substantially reduced in the bulk tumorand the tumor margins.